OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Genomics
(2)
Organisms
Homo sapiens
(2)
Repository
EGA
(2)
Technology Type
Illumina 1.2M, Affymetrix 6.0, Affymetrix 6.0 - CHIAMO
(1)
Publication Date
Release Date
2024
(2)
2021
(2)
2022
(1)
2018
(1)
2012
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Not available
S-EPMC7237199
|
biostudies-literature
Cite
PR
Pharmacogenomic response to Statins samples (Genotypes/Phenotypes)
EGAD00010000282
|
EGA
Cite
WTCCC2 Pharmacogenomic Response to Statins study
A WTCCC2 project genome-wide study for pharmacogenomic response to statins (PR) in individuals from Scotland.
EGAS00000000121
|
EGA
Cite
Characterizing Long COVID in Children and Adolescents.
Not available
S-EPMC11339705
|
biostudies-literature
Cite
Canadian Surgery Forum.
Not available
S-EPMC3432251
|
biostudies-literature
Cite
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692
|
biostudies-literature
Cite
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
Not available
S-EPMC8360544
|
biostudies-literature
Cite
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
Not available
S-EPMC10364875
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets